The plasma total triglyceride (TG) content was determined quantitatively by a colorimetric (at 570 nm) Triglyceride Assay kit (Cayman Chemical, Ann Arbor, MI) according to instructions. Plasma cholesterol levels were determined by a Cholesterol Fluorometric Assay kit (Cayman Chemical), and total cholesterol content for each sample was estimated on the basis of relative fluorescence (excitation 550 nm, emission 590) obtained from standards. Plasma 8-isoprostane levels at 18 weeks were determined by a Cayman Enzyme Immunoassay Kit as described [8 (link), 17 (link)–19 (link)]. RBC reduced (GSH) and oxidized (GSSG) glutathione levels were assessed enzymatically by the DTNB-GSSG reductase method [17 (link)–19 (link)]. Plasma 3-nitrotyrosine (3-NT) results, determined by the enzyme immunoassay components from Cayman Chemical, were derived from the concurrent study just published [8 (link)].
Free full text: Click here